Demand for Airway Management Devices Market

The airway management devices market is projected to reach USD 2.4 billion by 2028 from USD 1.8 billion in 2022, at a CAGR of 5.6%

The global market for airway management devices is estimated to grow at a compound annual growth rate (CAGR) of 5.6% from 2022 to 2028, increasing from $1.8 billion in 2022 to $2.4 billion by 2028. Several key factors are driving this projected market expansion.

A major driver is the rising incidence of preterm births worldwide. Premature babies often experience breathing issues requiring airway management devices and mechanical ventilation. With preterm birth rates climbing, demand for neonatal/pediatric airway products is surging. Vendors are responding by offering size-appropriate devices for this patient population.

Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116806061

Another catalyst is the increasing prevalence of chronic respiratory diseases like COPD and asthma, which elevates the need for airway management, especially during surgical procedures requiring anesthesia. The anesthesia application segment currently commands the largest market share due to the growing number of surgical interventions globally.

Developing countries represent an attractive growth opportunity for airway device manufacturers. Nations like China, India, and Brazil have large patient populations and are becoming major medical tourism destinations offering affordable surgical procedures compared to developed nations. This is expected to drive demand for anesthesia and associated airway management products.

However, the market faces some headwinds. Lack of reimbursement policies and limited public healthcare coverage in emerging economies restricts adoption of more expensive airway devices due to high out-of-pocket costs for patients. Additionally, a shortage of skilled anesthetists and nurses trained in complex airway procedures like tracheostomies poses a challenge.

Looking at product segments, infraglottic devices like endotracheal tubes are projected to see the highest growth rate, fueled by rising respiratory failure cases. The pediatric patient segment is also anticipated to grow rapidly alongside preterm birth trends.

Geographically, North America currently dominates the global market, benefiting from advanced healthcare infrastructure, high chronic disease rates, and favorable reimbursement policies. However, Asia-Pacific nations are expected to be a key driver of future market expansion.

Major players in the airway management space include Medtronic, ICU Medical, Teleflex, Ambu, and ConvaTec. Recent industry developments include partnerships, acquisitions, and new product launches aimed at enhancing patient safety, broadening portfolios, and tapping new markets.

Medtronic (Ireland)

Medtronic (Ireland) is a leading player in the airway management devices market in 2022. The company’s products and therapies are used primarily by hospitals, physician offices, healthcare systems, ambulatory care centers, and other alternate-site healthcare providers. The company has a significant presence in more than 150 countries, which maintains its global market position. The company has also invested a significant amount of its revenue in R&D in bringing innovative products to this market space. In this regard, the company invested about USD 2.7 billion in R&D in 2022.

 ICU Medical, Inc. (US),

ICU Medical, Inc. is a leading player of the airway management devices market in 2022. The company invested USD 93.0 Million in R&D activities in 2022. A significant focus on R&D activities helps the company provide innovative products and maintain and improve its competitive position in the market. The company’s products are used across acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities. With its broad product portfolio, acquisitions, and wide geographic presence the company operates in more than 100 countries across US, Costa Rica, Mexico, and the Czech Republic.

The company has created a strong foothold in the airway management devices market due to its diversified product portfolio and its focus on organic business strategies.

Teleflex Incorporated (US)

Teleflex Incorporated is an important player in the airway management devices market. Teleflex Incorporated primarily designs, develops, manufactures, and supplies single-use medical devices used by hospitals and healthcare providers.  The company has a strong presence across 150 countries spanning North America, Europe, and the Asia Pacific. The company serves three end markets, namely, hospitals and healthcare providers, medical device manufacturers, and home care. In 2021, the company spent USD 130.8 Million on R&D. R&D initiatives of the company develop innovative and cost-effective products.

Overall, while facing some hurdles, the global airway management devices market is forecasted for robust growth over the next several years, propelled by increasing disease burdens, surgical volumes, and healthcare demands across both developed and emerging markets.